MetaCap

Capstone (CAPS) vs PRF Technologies (PRFX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

PRF Technologies is the larger company by market cap ($1.7 million vs $1.3 million), about 1.2 times the size. Capstone converts more of its revenue into profit, with a net margin of -45.3% versus -29541.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CAPS+927.84%PRFX-45.79%
+2018%+937%-144%
Oct 7, 20261 yearNov 20, 2026
CAPS+949.56%PRFX-45.86%
+1879%+871%-138%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CAPS versus PRFX key metrics
MetricCAPSPRFX
Share price$1.44$0.4758
Market cap$1.35M$1.66M
1-day change-9.15%-23.68%
EPS (TTM)$-89.68$-4.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$46.88M$17.00K
Revenue growth (YoY)+4.47%—
Net income (latest FY)$-21.23M$-5.02M
Gross margin23.02%-311.76%
Operating margin-23.43%-30129.41%
Net margin-45.28%-29541.18%
52-week high$28.50$7.95
52-week low$1.42$0.46
Distance from 52-week high-94.95%-94.02%
Analyst consensusnone—
Avg. price target upside+108.33%—
Average volume153.70K228.55K
Shares outstanding935.38K3.50M
Employees936
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Capstone is more profitable, keeping -45.3 cents of every revenue dollar as net income versus -29541.2 cents for PRF Technologies.

About Capstone

CAPS stock →

Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.

Health Care · Biotechnology: Pharmaceutical Preparations · 93 employees

About PRF Technologies

PRFX stock →

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

CAPS vs PRFX FAQ

Which is bigger, Capstone or PRF Technologies?

PRF Technologies (PRFX) is larger, with a market capitalization of $1.66M compared with $1.35M for Capstone (CAPS).

Are Capstone and PRF Technologies in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons